A review of antiplatelet drugs, coronary artery diseases and cardiopulmonary bypass.

about

A review of antiplatelet drugs, coronary artery diseases and cardiopulmonary bypass.

Item

http://www.wikidata.org/entity/Q36374457

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

A review of antiplatelet drugs, coronary artery diseases and cardiopulmonary bypass.

@ast

A review of antiplatelet drugs, coronary artery diseases and cardiopulmonary bypass.

@en

type

Item

label

A review of antiplatelet drugs, coronary artery diseases and cardiopulmonary bypass.

@ast

A review of antiplatelet drugs, coronary artery diseases and cardiopulmonary bypass.

@en

prefLabel

A review of antiplatelet drugs, coronary artery diseases and cardiopulmonary bypass.

@ast

A review of antiplatelet drugs, coronary artery diseases and cardiopulmonary bypass.

@en

P1476

A review of antiplatelet drugs, coronary artery diseases and cardiopulmonary bypass.

@en

P2093

Kirti Patel

http://www.w3.org/2001/XMLSchema#string

Terry Crane

http://www.w3.org/2001/XMLSchema#string

Yajun Ren

http://www.w3.org/2001/XMLSchema#string

P2860

CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin

A comparison of aspirin and anticoagulation following thrombolysis for myocardial infarction (the AFTER study): a multicentre unblinded randomised clinical trial

Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T Kozak (GP Ibalpha) polymorphisms

Does clopidogrel increase blood loss following coronary artery bypass surgery?

Aspirin resistance: position paper of the Working Group on Aspirin Resistance

Individual dosing of ASA prophylaxis by controlling platelet aggregation

Profile and prevalence of aspirin resistance in patients with cardiovascular disease

P304

103-113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20648894

http://www.w3.org/2001/XMLSchema#string

P932

4680033

http://www.w3.org/2001/XMLSchema#string